Overview

Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease

Status:
Completed
Trial end date:
2009-05-28
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and gather additional safety of Prochymal in subjects who have failed to respond to steroid treatment of Grades B-D acute GVHD.
Phase:
Phase 3
Details
Lead Sponsor:
Mesoblast, Inc.
Treatments:
Remestemcel-l